日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population

改善肺癌筛查选择:西欧普通人群风险模型与传统标准的比较分析

Zhong, Danrong; Sidorenkov, Grigory; Greuter, Marcel J W; Jacobs, Colin; de Jong, Pim A; Gietema, Hester A; Groen, Harry J M; Mohamed Hoesein, Firdaus A A; Antonissen, Noa; Stadhouders, Ralph; Lancaster, Harriet L; Heuvelmans, Marjolein A; Vliegenthart, Rozemarijn; de Bock, Geertruida H

Repeatability of automated body composition measurement on low dose chest CT in male subjects

低剂量胸部CT对男性受试者自动体成分测量的重复性

Bunk, Stijn; Bennink, Edwin; Sidorenkov, Grigory; Gietema, Hester; Groen, Harry; de Bock, Geertruida; de Jong, Pim A; Vliegenthart, Rozemarijn; Mohamed Hoesein, Firdaus

A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials

两项随机对照试验中肺癌筛查效果异质性的比较分析

Welz, Max; van der Aalst, Carlijn M; Alfons, Andreas; Naghi, Andrea A; Heuvelmans, Marjolein A; Groen, Harry J M; de Jong, Pim A; Aerts, Joachim; Oudkerk, Matthijs; de Koning, Harry J; Ten Haaf, Kevin

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

基于无细胞DNA的下一代测序无法区分接受免疫检查点抑制剂治疗的非小细胞肺癌患者的寡转移进展和系统性进展——一项探索性研究

Rozendal, Pim; Kievit, Hanneke; van der Leest, Paul; Bahce, Idris; Pegtel, Michiel; Groen, Harry J M; van Kempen, Léon C; Hiltermann, T Jeroen N; Schuuring, Ed

Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling study

NELSON筛查方案检测肺癌的分期和组织学特异性敏感性——一项建模研究

de Nijs, Koen; Ten Haaf, Kevin; Hubert, Juul; Moldovanu, Dana; van der Aalst, Carlijn M; Groen, Harry J M; de Jong, Pim A; Heuvelmans, Marjolein A; Oudkerk, Matthijs; de Koning, Harry J

The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients

ROS1融合伴侣和耐药机制对接受ROS1-TKI治疗的非小细胞肺癌患者的影响

Zwierenga, Fenneke; Dijkhuizen, Christa; Korthuis, Patrick; Timens, Wim; Groen, Harry; Hiltermann, Jeroen; van den Berg, Anke; Drayer, Lyndsay; van der Wekken, Anthonie

Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients

ALK融合基因阳性肺癌患者治疗前样本中靶向耐药突变的存在

Li, Weiting; Zwierenga, Fenneke; Andini, Katarina D; Bucher, Justyna M; Scherpen, Frank; Hiltermann, T Jeroen N; Groen, Harry J M; van der Wekken, Anthonie J; Kok, Klaas; Berg, Anke van den

Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease

基于模型的低剂量计算机断层扫描联合筛查肺癌、慢性阻塞性肺病和心血管疾病的成本效用分析

Behr, Carina M; IJzerman, Maarten J; Kip, Michelle M A; Groen, Harry J M; Heuvelmans, Marjolein A; van den Berge, Maarten; van der Harst, Pim; Vonder, Marleen; Vliegenthart, Rozemarijn; Koffijberg, Hendrik

Erratum to 'Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100813]

对“基于模型的肺癌、慢性阻塞性肺病和心血管疾病联合低剂量计算机断层扫描筛查的成本效用分析”的勘误 [JTO 临床与研究报告 第 6 卷 第 5 期 (2025) 100813]

Behr, Carina M; IJzerman, Maarten J; Kip, Michelle M A; Groen, Harry J M; Heuvelmans, Marjolein A; van den Berge, Maarten; van der Harst, Pim; Vonder, Marleen; Vliegenthart, Rozemarijn; Koffijberg, Hendrik

Incorporating High-Risk Individuals Beyond Smoking History Into Lung Cancer Screening in Hong Kong: A Cost-Effectiveness Study

将吸烟史以外的高危人群纳入香港肺癌筛查:一项成本效益研究

Loong, Herbert Ho-Fung; Pan, Xuanqi; Wong, Carlos K H; Chiu, Chao-Hua; Yang, Szu-Chun; Chung, Matthew Shing Hin; Ching Li, Molly Siu; de Jong, Lisa; Groen, Harry; Postma, Maarten J; Yang, Pan-Chyr